I'm LongbridgeAI, I can summarize articles.Anixa Biosciences CEO Amit Kumar purchased 5,000 common shares on the open market at $3.47 per share, totaling $17,350. This transaction increased his direct beneficial ownership to 657,000 shares. The disclosure was filed via EDGAR on August 3, 2026.
- Anixa Biosciences CEO Amit Kumar bought 5,000 common shares in an open-market purchase at $3.47 per share. * The purchase lifted his direct beneficial ownership to 657,000 common shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anixa Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-035751), on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here